George G. Spellman Jr, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: Although Dr. Ihde (1) awaits the end of the beginning in efforts to treat unresectable lung cancer, many clinicians and patients await the beginning of the beginning. Medical research has provided little information on the "no treatment" alternative for patients who are deciding whether to have traditional thoracic radiation, making informed consent difficult.
A retrospective chart review of 16 patients with unresectable carcinoma of the lung, who died in the past 4 years after having declined cancer therapy, revealed 1-, 2-, and 5-year survival rates of 50%, 31%, and 13%, respectively. These data support Johnson and colleagues'
Spellman GG. Does Radiation Increase Survival in Nonresectable Lung Cancer?. Ann Intern Med. 1992;116:524–525. doi: https://doi.org/10.7326/0003-4819-116-6-524_2
Download citation file:
Published: Ann Intern Med. 1992;116(6):524-525.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use